Objectives -To detennine the detection rate, false positive and false negative rates associated with a policy of retesting with dietary restriction after an initial positive Haemoccult screening test for colorectal cancer, in order to compare the cost effectiveness of such a policy with the alternative, in which all subjects with a positive test would proceed directly to diagnostic colonoscopy. Methods -Over four years in a large randomised control trial in Nottingham 35 260 subjects had a mean of 1· 5 screening rounds each at two-yearly intervals, and were followed up for a minimum of 27 months. During this period subjects with positive screening tests were asked to repeat the test with dietary restrictions. Estimates of costs of the initial screening and of diagnostic colonoscopy were used to estimate the cost for each cancer detected by the different policies. Results -1209 subjects had a positive initial screening test and 1033 (85·4%) completed the retests. Four hundred and ninety nine subjects were investigated and 89 cancers detected. In the 710 subjects with negative retests six interval cancers were diagnosed in the two years after screening. If these had been detected by screening under a policy of immediate colonoscopy, test sensitivity would have been improved from 53·6% to 57·2% (p=0·02), but the cost for each cancer detected would have increased from £773 to £1509. Conclusion -Retesting with dietary restrictions reduces costs and maximises the benefit of limited colonoscopy resources, but results in a small but significant reduction in test sensitivity compared with a policy for immediate colonoscopy.
Abstract
Objectives -To detennine the detection rate, false positive and false negative rates associated with a policy of retesting with dietary restriction after an initial positive Haemoccult screening test for colorectal cancer, in order to compare the cost effectiveness of such a policy with the alternative, in which all subjects with a positive test would proceed directly to diagnostic colonoscopy. Methods -Over four years in a large randomised control trial in Nottingham 35 260 subjects had a mean of 1· 5 screening rounds each at two-yearly intervals, and were followed up for a minimum of 27 months. During this period subjects with positive screening tests were asked to repeat the test with dietary restrictions. Estimates of costs of the initial screening and of diagnostic colonoscopy were used to estimate the cost for each cancer detected by the different policies. Results -1209 subjects had a positive initial screening test and 1033 (85·4%) completed the retests. Four hundred and ninety nine subjects were investigated and 89 cancers detected. In the 710 subjects with negative retests six interval cancers were diagnosed in the two years after screening. If these had been detected by screening under a policy of immediate colonoscopy, test sensitivity would have been improved from 53·6% to 57·2% (p=0·02), but the cost for each cancer detected would have increased from £773 to £1509. Conclusion -Retesting with dietary restrictions reduces costs and maximises the benefit of limited colonoscopy resources, but results in a small but significant reduction in test sensitivity compared with a policy for immediate colonoscopy.
Four European randomised controlled trials investigating the role of Haemoccult (Rohm Pharma, Weiterstadt, FRG) in screening for colorectal cancer have shown that such screening can detect cancers at an early stage,1-4 and a trial in the United States has shown a reduction in mortality from colorectal cancer associated with annual screening."
Although colorectal cancers bleed, this is variable and intermittent and there is overlap with the physiological losses occurring in nor-mal subjects." While striving to maximise the number of cancers detected, it is important that the threshold for detection of blood is sufficiently high so that few healthy individuals are investigated unnecessarily. This is particularly important in colorectal cancer screening where the diagnostic investigation of choice is colonoscopy. This examination is both expensive? and potentially hazardous" with limited facilities for its practice in this country.
The Haemoccult test relies on the peroxidase-like activity of haematin to give a positive reaction, which may also occur after ingestion of animal haemoglobin or foods containing naturally occurring peroxidases.t " Dietary interference may therefore be a potential source of false positive error.
The imposition of dietary restrictions on those asked to complete the tests, as practised in the Danish study," has resulted in reduced compliance with screening" when practised in Britain.
We investigated the sensitivity and cost implications of such a policy by following up subjects with initial positive test results but who did not undergo colonoscopy because the diet restricted retests were negative or were not done.
Patients and methods
A large randomised controlled trial of faecal occult blood testing in the early detection of colorectal cancer has been taking place in Nottingham since 1981.I Subjects in the study group are invited to complete a Haemoccult test, with no dietary restrictions imposed. All subjects accepting the initial invitation to screening are offered further tests at two-yearly intervals. Since May 1986 subjects with positive results have been asked to repeat the test after excluding red meat and vegetables with high peroxidase content from their diet. If the result of the second test is also positive, patients are referred for diagnostic colonoscopy. Because blood loss is intermirtent," those with negative retests are offered a further test after three months, once again over six days with dietary restrictions, and if the result is positive a diagnostic test is offered." In May 1987 it was shown that 88·1 % of subjects with five or more positive squares on initial testing remained positive at retesting, in contrast with 35·6% of subjects with only one to four squares that were initially positive. 14 
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screens were undertaken by 35260 test group subjects. Of these screens, 27 663 were initial screens, 18199 first rescreens, and 6492 second rescreens. Cancers occurring within a two year interval of a negative screen (either initially or on retesting) are classed as interval cancers, and test sensitivity is calculated as the number of such interval cancers as a proportion of the sum of screen detected and interval cancers. If it is assumed that all interval cancers occurring in subjects with a positive initial test, but negative on retesting, would have been detected by screening under a policy of immediate colonoscopy, the yield and sensitivity of the two policies can be compared.
Results
A total of 1209 subjects had 1290 screens, at which the initial Haemoccu1t test was positive when completed without dietary restrictions.
Only the first positive screen is included in this analysis. Eight hundred (2'9%) first screens and 409 (1'6%) rescreens in subjects with negative previous screens were positive. The figure shows the effect of retesting with dietary restriction on the need for colonoscopy and cancer yield.
COLORECTAL CANCER YIELD
During the study and its follow up 166 cancers were diagnosed among those completing the Haemoccu1t tests. The cancers fell into one of three groups:
(a) Eighty nine cancers detected by screening, which were located by investigating patients with positive test results. (b) Six initial test positive, retest negative interval cancers, These were detected subsequently in subjects presenting with symptomatic colorectal cancer in the two year interval following an initial positive test. They were not investigated at the time of the first positive test, however, because their retests were negative or they had refused retesting. (c) Seventy one true interval cancers in subjects presenting symptomatically whose tests at the previous screening round were negative.
The six cancers with initial test positive, retest negative might have been detected earlier with a policy of immediate colonoscopy.
The dietary restriction policy can be compared with an alternative policy of immediate colonoscopy of all subjects with any positive test.
SENSITIVITY
It is conventional to classify colorectal cancers diagnosed in the two year interval following a negative screen ("interval cancers") as false negatives. The assumption is that they were present at the time of screening but were missed by it. One method of estimating sensitivity is to express the number of cancers detected by screening as a proportion of the sum of screen detected and interval cancers over a two year follow up period after screening.
Six patients presented in the two year interval after an initial positive test while 89 were de- 
INVESTIGATION COST PER CANCER DETECTED
An earlier estimate of the costs of the screening programme found that at 1989 prices the average cost of purchasing, distributing, and testing Haemoccult kits was £5.33 for each person tested, and the average cost of further investigation of those testing positive was £118.60. 15 When these cost estimates are applied to the data in the figure, and when the cost ofthe initial screening test, which is common to both policies, is excluded the total cost of further investigations under the dietary restriction retesting policy is £68 817 (includes the full cost of Haemoccult processing in those refusing at retesting), or £773 for each cancer detected. Under the immediate colonoscopy policy the investigation cost would be £143387 (assumes 100% compliance), or £1509 for each cancer detected. The marginal extra cost for each of the six cancers, which it is assumed might have been detected by the immediate colonoscopy policy, is £143387 minus £68817 divided by six, or £12428 for each case (table) .
Conclusion
The policy of retesting with dietary restrictions is clearly cost efficient. It would be unwieldy to administer on a large scale, however, and
Discussion
Six cancers presented symptomatically among subjects with an initial positive test but who were not further investigated, either because they refused retesting or were found to be negative at retesting. Three assumptions about these six additional cancers are tacitly made. The first is that all cancers present would have been detected by appropriate investigation of the positive tests. Colonoscopy is widely accepted as the most sensitive investigation16 and, in the screening study to date, more than 95% of those offered have accepted it. Secondly, we have assumed that the cancers "missed" were not adenomas at the time of testing. The available evidence on the likelihood and rate of progression of large adenomas (;;?: 1 ern) to carcinoma" suggests that these cancers would not have been adenomas at the time of testing. This is reinforced by the fact that none of the six cancers were at stage A at presentation. Furthermore, even if the tumours were adenomas at the time of the original tests, it is likely that they would have been identified and removed at colonoscopy. Finally, it is assumed that investigation of these retest negative subjects would have shown no further cancers still waiting to present symptomatically. The median follow up of subjects screened is 47 months. Despite uncertainty about the natural history of colorectal cancer, this long follow up suggests that few if any cancers remain to be detected.
Is the protocol of dietary restriction retesting to be recommended? The rationale for such a policy, when using Haemoccult to screen for colorectal cancer, is that a proportion of patients will have positive tests attributable to naturally occurring dietary peroxidases or animal haemoglobin.t " The elimination of these false positives by retesting all subjects submitting a positive test under conditions of dietary restriction and investigating only those that remain positive significantly increased positive predictive value of the test under conditions of diet restriction. A concern with the policy is that the interval cancer rate for subjects where the initial test was positive but "became" negative on retesting is more than six times higher than those where the initial test was negative (6/710 v 71/52354-1290) =0·85% v 0'14%). It is of note that the substantial increase in risk for these patients is of the same order of magnitude greater than the population risk as that for patients with at least one first degree relative with coloreetal cancer. There is growing support for recommending and practising colonoscopy in individuals with such a positive family history. On the basis of the data presented, a doctor whose patient has an initial positive test and is therefore at high risk of neoplasia will be warranted in requesting that his patient be investigated further (whatever the result of the retest). those subjects with an initial positive test but whose retests are negative are themselves a high risk group. With limited resources for colonoscopy in the United Kingdom at the present time, a policy of retesting may be a sound compromise if screening is shown to be effective at reducing colorectal cancer mortality. With greater access to colonoscopy, however, it may be that subjects should simply be asked to complete three days of Haemoccult tests (there being no significant gain in neoplasia detected by more prolonged testing") without the need for any dietary modification. Any subject with a positive test would then be offered colonoscopy (in the absence of obvious contraindication). This would result in a colonoscopy rate of 2·9% at initial screening falling to 1·6% at subsequent screens. Both are lower values than the rate of abnormal smears or abnormal mammograms in programmes for the early detection of cervical or breast cancer respectively.
